Finding 946002 (2022-001)

Significant Deficiency Repeat Finding
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2024-02-16

AI Summary

  • Core Issue: The Institute failed to submit the Single Audit reporting package on time, missing the September 30, 2023 deadline.
  • Impacted Requirements: This violation relates to 2 CFR 200.512, which mandates timely submission of audit reports.
  • Recommended Follow-Up: Review and strengthen internal controls over year-end closing to ensure timely submissions in the future.

Finding Text

Significant Deficiency in Internal Controls over Compliance for Reporting related to the Submission of Single Audit reporting package. Federal Agency: All Awards within the Research and Development Cluster Program Title: All Awards within the Research and Development Cluster Assistance Listing Number: All Awards within the Research and Development Cluster Award Number: All Awards within the Research and Development Cluster Award Period: All Awards within the Research and Development Cluster Criteria In accordance with 2 CFR 200.512 (as codified by DHHS in 45 CFR 75), the audit must be completed and the data collection form and reporting package must be submitted within the earlier of 30 calendar days after receipt of the auditor’s report(s), or nine months after the end of the audit period. Condition/Context for Evaluation The Institute did not submit its completed data collection form and reporting package for the Single Audit for the year ended December 31, 2022, by the due date of September 30, 2023. Effect or Potential Effect The internal controls in place allowed the reporting package and data collection form to be submitted more than nine months after the end of the audit period. Questioned Costs Not applicable. Cause Internal controls over year‐end closing were not in place to ensure timely filing. Repeat Finding Repeat of finding 2021-002. Recommendation We recommend that the Institute review the internal controls in place over year‐end closing to ensure the data collection form and reporting package can be submitted timely to the Federal Audit Clearinghouse. Views of Responsible Officials of Auditee Management agrees with the finding and has provided the accompanying corrective action plan.

Categories

Reporting Significant Deficiency Internal Control / Segregation of Duties

Other Findings in this Audit

  • 369558 2022-001
    Significant Deficiency Repeat
  • 369559 2022-001
    Significant Deficiency Repeat
  • 369560 2022-001
    Significant Deficiency Repeat
  • 369561 2022-001
    Significant Deficiency Repeat
  • 369562 2022-001
    Significant Deficiency Repeat
  • 369563 2022-001
    Significant Deficiency Repeat
  • 369564 2022-001
    Significant Deficiency Repeat
  • 369565 2022-001
    Significant Deficiency Repeat
  • 946000 2022-001
    Significant Deficiency Repeat
  • 946001 2022-001
    Significant Deficiency Repeat
  • 946003 2022-001
    Significant Deficiency Repeat
  • 946004 2022-001
    Significant Deficiency Repeat
  • 946005 2022-001
    Significant Deficiency Repeat
  • 946006 2022-001
    Significant Deficiency Repeat
  • 946007 2022-001
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.839 Blood Diseases and Resources Research $220,549
93.172 Human Genome Research $201,570
93.866 Aging Research $167,671
93.395 Cancer Treatment Research $125,713
93.396 Cancer Biology Research $15,508